Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies said after the close of the market on Monday that its preliminary second quarter revenues grew about 11 percent year over year, exceeding previous guidance.

The company also announced a $50 million underwritten public offering of its common stock, pursuant to an existing shelf registration statement. In connection with the offering, NanoString said it also expects to grant underwriters a 30-day option to purchase up to $7.5 million worth of additional common shares.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.